Pharmaceutical Development of Innovative "Trojan Horse" Anti-Cancer Agents that Inhibit Desmoplasia by Reprogramming Signalling (NHMRC Ideas Grant administered by Griffith University) (2023–2025)
- Grant type:
- Griffith University
- Researchers:
-
-
- Funded by:
- Griffith University
